Measuring disease progression in giant axonal neuropathy: implications for clinical trial design.
about
Measuring disease progression in giant axonal neuropathy: implications for clinical trial design.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Measuring disease progression ...... ons for clinical trial design.
@en
Measuring disease progression ...... ons for clinical trial design.
@nl
type
label
Measuring disease progression ...... ons for clinical trial design.
@en
Measuring disease progression ...... ons for clinical trial design.
@nl
prefLabel
Measuring disease progression ...... ons for clinical trial design.
@en
Measuring disease progression ...... ons for clinical trial design.
@nl
P2093
P2860
P356
P1476
Measuring disease progression ...... ons for clinical trial design.
@en
P2093
Douglas M Sproule
Jonathan D Marra
Lisa A Roth
Nicole H LaMarca
P2860
P304
P356
10.1177/0883073814542946
P577
2014-09-03T00:00:00Z